Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Conflicting studies on besipirdine

June 21, 1996

5-HT1A agonist for cognition disorders disclosed

June 21, 1996

Alzheimer's beta-protein inhibition method described

June 21, 1996

Cholinergic agonists claimed by Lilly

June 21, 1996

Anergen's MS-AnergiX enters phase I for MS

June 21, 1996

Agents for multiple sclerosis disclosed

June 21, 1996

Discovery Therapeutic's N-0923 trial results to be presented

June 21, 1996

Peptides resembling h-MBP claimed

June 21, 1996

COMT inhibitor disclosed by Roche

June 21, 1996

Taro's anticonvulsant drug undergoes development

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...